Christopher Groux is an editor, writer and accessibility advocate. Before joining the Forbes Health team, he covered Accessibility at Reviewed and gaming at Inverse and Newsweek. When he’s not ...

Millions of Americans use weed to treat chronic pain, but there's little high quality research on whether it works. New ...

The FDA does not approve CBD products, so it’s up to consumers to sort out good from bad as they shop for CBD. Many CBD products are not accurately labeled, so it’s important to choose a product that ...

Millions of Americans use weed to treat chronic pain, but there's little high quality research on whether it works. New ...

CBD gummies contain cannabidiol (CBD), a chemical present in the cannabis plant. While research suggests potential benefits, like reduced anxiety and pain relief, some people may experience negative ...

In a 2023 Healthline survey, 79% of those who reported being interested in trying CBD said they were specifically interested in CBD gummies. And while older adults are interested in CBD as a pain ...

Millions of Americans use weed to treat chronic pain, but there's little high quality research on whether it works. New ...

As an editor and writer who has contributed to many national and local publications, Nicole Gregory enjoys communicating clearly on critical health topics so that readers can make informed choices for ...

U.S. oil production is setting new records, but the rate of growth is slowing down for the first time in 20 years without an external crisis, driven by internal factors. The slowdown is attributed to ...

Iraq expects crude oil exports from the semi-autonomous region of Kurdistan via pipeline to Turkey to resume this week, Iraqi Foreign Minister Fuad Hussein has told Bloomberg in an interview. Oil ...

An experimental cannabis extract reduced low back pain in a randomized, placebo-controlled trial in Europe, and Canadian doctors say it's the type of well-designed study they'll need to guide patients ...